Skip to main content
Premium Trial:

Request an Annual Quote

What to Do About Review

At Open …, Glyn Moody recently blogged that peer review, at least as it is done now, is not necessary. Moody writes that the system was set up in a time when opportunities to publish were scarce and "needed husbanding." Today though, Moody says that with the Internet, there are a plethora of publishing opportunities and "there are all kinds of systems that allow any scientist — or even the general public — to rate content and to vote it up towards a wider audience."

Deepak Singh at business|bytes|genes|molecules says he disagrees even though he is "not a huge fan of the current peer-review system." Singh writes that peer review can be a source of advice that improves the quality of science. He does, however, say that what goes through the peer-review process should be changed. "To put this another way, with peer-review we should be focussing on a subset of what we publish today, while the rest goes into blogs, Nature Precedings, self-published articles, etc," he writes.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.